Sentences with phrase «cell vaccine technology»
Grant Title: 01787: Clinical advancement of RNA - transfected CD40 - B cell vaccine technology for cancer therapy
http://www.oldenglishsheepdogclubofamerica.org/ Not exact matches
Today his company is developing a new cancer vaccine technology that teaches immune cells how to recognize and remove tumor cells.
Moderna is a clinical stage pioneer of messenger RNA (mRNA) therapeutics and vaccines, an entirely new drug technology that directs the body's cells to produce intracellular or secreted proteins.
Currently, most influenza vaccines in the United States are produced using chicken eggs, while a few are made in cell culture or by using recombinant DNA technologies.
«It's a powerful vaccine technology that efficiently delivers vaccine components to the right cells in the right tissues.
The technology also improves cell culture systems used to produce therapeutic proteins, vaccines, and gene therapy vectors.
Cancer Vaccine Collaborative researchers Danila Valmori, Maha Ayyoub, Immanuel Luescher, and colleagues develop the first tetramer technology to monitor CD4 T cell responses to cancer vaccination.
Massachusetts Institute of Technology (MIT) researchers have discovered a new way to model malaria using stem cells in a petri dish, which will allow them to test potential antimalarial drugs and vaccines.
Scientific programs include: human genomic sequencing and analysis, synthetic genomics and exploration of new vaccines using this technology, and environmental and single cell genomics to explore the vast unseen world of microbes living in the human body, the ocean, soil and air.
Important reports from the Weiner lab include the first DNA vaccine studied for HIV as well as for cancer immune therapy of cutaneous T cell lymphoma, the early development of DNA encoded genetic adjuvants, including IL - 12, advances in gene optimization, and advances in electroporation technologies resulting in improved gene delivery.
VXGN has other potentially valuable assets, including a «a state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products» and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology.
VXGN has other potentially valuable assets, including a «state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products» and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology.
Flublok's novel manufacturing technology allows for production of large quantities of the influenza virus protein, hemagglutinin (HA)-- the active ingredient in all inactivated influenza vaccines that is essential for entry of the virus into cells in the body.